Skip to main content
Loading
Join
About
MySLAS
Log Out
CONNECTED
APPLIED Learning
Search
EVENTS
Events Calendar
Symposia
Meet-Ups
SLAS2024 International Conference and Exhibition
SLAS Europe 2024 Conference and Exhibition
SLAS Ignite
Boost Your Brand
PUBLICATIONS
SLAS Discovery
SLAS Technology
Electronic Laboratory Neighborhood
Point-to-Point (P2P) e-newsletter
MEMBERSHIP
Membership Types and Benefits
Member Directory
Corporate Partner Program
SLAS Fellow Member Program
Statement of Conduct
EDUCATION
SLAS Ignite
APPLIED Online Learning
Lab of the Future
Micro-Credentials Program
New Matter Podcast
Webinars
Short Courses
ANSI/SLAS Microplate Standards
RESOURCES
Student Resources
Awards and Grants
Job Board: Find/Post a Job
Mentor Match
CONNECTED
Special Interest Groups
Get Involved in SLAS!
NEWS & HIGHLIGHTS
News Center
President's Monthly Message
COVID-19 Resources
SLAS Marketplace
Join
About
Log In
CONNECTED Networking
APPLIED Learning
Search
EVENTS
Events Calendar
Symposia
Meet-Ups
SLAS2024 International Conference and Exhibition
SLAS Europe 2024 Conference and Exhibition
SLAS Ignite
Boost Your Brand
PUBLICATIONS
SLAS Discovery
SLAS Technology
Electronic Laboratory Neighborhood
Point-to-Point (P2P) e-newsletter
MEMBERSHIP
Membership Types and Benefits
Member Directory
Corporate Partner Program
SLAS Fellow Member Program
Statement of Conduct
EDUCATION
SLAS Ignite
APPLIED Online Learning
Lab of the Future
Micro-Credentials Program
New Matter Podcast
Webinars
Short Courses
ANSI/SLAS Microplate Standards
RESOURCES
Student Resources
Awards and Grants
Job Board: Find/Post a Job
Mentor Match
CONNECTED
Special Interest Groups
Get Involved in SLAS!
NEWS & HIGHLIGHTS
News Center
President's Monthly Message
COVID-19 Resources
SLAS Marketplace
Item Detail - Redefining Pre-Clinical Testing in Oncology:
Redefining Pre-Clinical Testing in Oncology:
Redefining Pre-Clinical Testing in Oncology: Why We Need to Go 3D- Recording
In the last ten years, there has been a dramatic surge in the number of publications where single or groups of cells are grown in substrata that have elements of basement membrane leading to the formation of tissue-like structures referred to as organoids. Moreover, evidence is accumulating that the development of organoid platforms represents a unique opportunity to redefine the traditional way of carrying out pre-clinical testing of new therapeutic strategies for cancer. This is critical given the low percentage of drugs that entering phase 1 actually make it to the clinic (5% in oncology). We will cover a historical perspective of the development of 3D-culture systems and show clear examples of how these new platforms represent a unique opportunity to improve the efficacy of the drug-development process.
FREE for SLAS Members
$20 SLAS Non-Members
Discounted price:
0.00
Your price:
20.00
Quantity:
Quantity is required.
Quantity must be a positive whole number.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##